Advertisement

Enteric alpha-synuclein expression is increased in Crohn’s disease

  • Alice Prigent
  • Arthur Lionnet
  • Emilie Durieu
  • Guillaume Chapelet
  • Arnaud Bourreille
  • Michel Neunlist
  • Malvyne Rolli-Derkinderen
  • Pascal Derkinderen
Correspondence

An accumulating body of evidence has emerged in the last decade to suggest that gastrointestinal (GI) inflammation might be involved in the development of Parkinson’s disease (PD). Elevated levels of proinflammatory cytokines [3] and fecal markers of inflammation have been reported in PD patients [5]. Data from genetic studies further support the close relationship between PD and GI inflammation as PD and Crohn’s disease (CD) share common causative and susceptibility genes such as leucine-rich repeat kinase 2 (LRRK2) and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) (reviewed in [2]). Two recent large epidemiological studies, by showing an increased risk of subsequent PD in patients with inflammatory bowel disease (IBD) when compared with non-IBD subjects, tie even closer together these two disorders [4, 7].

The mechanisms by which gastrointestinal inflammation might influence PD development or progression are still unclear. A recent report showed that...

Notes

Acknowledgements

This work was supported by a grant from centre d’entraide et de coordination des associations de parkinsoniens (CECAP) and Parkinsonien de Vendée (FFGP) to AP and PD and Institut de France to PD.

Author’s contribution

AP, AL, ED, GC and MRD performed the experiments. AB, ED, MN and MRD were involved in tissue sampling and biobanking. MRD and PD supervised the study, wrote the first draft and the final version of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare no actual or potential conflict of interest.

Supplementary material

401_2018_1943_MOESM1_ESM.pdf (234 kb)
Supplementary material 1 (PDF 233 kb)
401_2018_1943_MOESM2_ESM.docx (21 kb)
Supplementary material 2 (DOCX 21 kb)
401_2018_1943_MOESM3_ESM.pdf (1008 kb)
Supplementary material 3 (PDF 1007 kb)
401_2018_1943_MOESM4_ESM.pdf (2.3 mb)
Supplementary material 4 (PDF 2396 kb)

References

  1. 1.
    Christophi GP, Rong R, Holtzapple PG, Massa PT, Landas SK (2012) Immune markers and differential signaling networks in ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis 18:2342–2356.  https://doi.org/10.1002/ibd.22957 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Derkinderen P, Neunlist M (2018) Crohn’s and Parkinson disease: is LRRK2 lurking around the corner? Nat Rev Gastroenterol Hepatol.  https://doi.org/10.1038/s41575-018-0006-9 CrossRefPubMedGoogle Scholar
  3. 3.
    Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H et al (2013) Colonic inflammation in Parkinson’s disease. Neurobiol Dis 50:42–48.  https://doi.org/10.1016/j.nbd.2012.09.007 CrossRefPubMedGoogle Scholar
  4. 4.
    Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N et al (2018) Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurol.  https://doi.org/10.1001/jamaneurol.2018.0605 CrossRefPubMedGoogle Scholar
  5. 5.
    Schwiertz A, Spiegel J, Dillmann U, Grundmann D, Bürmann J, Faßbender K et al (2018) Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson’s disease. Parkinsonism Relat Disord.  https://doi.org/10.1016/j.parkreldis.2018.02.022 CrossRefPubMedGoogle Scholar
  6. 6.
    Stolzenberg E, Berry D, Yang D, Lee EY, Kroemer A, Kaufman S et al (2017) A Role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun 9:456–463.  https://doi.org/10.1159/000477990 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T (2018) Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014. Gut.  https://doi.org/10.1136/gutjnl-2017-315666 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Alice Prigent
    • 1
    • 2
    • 3
  • Arthur Lionnet
    • 1
    • 2
    • 4
  • Emilie Durieu
    • 1
    • 2
    • 3
  • Guillaume Chapelet
    • 1
    • 2
  • Arnaud Bourreille
    • 1
    • 2
    • 3
  • Michel Neunlist
    • 1
    • 2
    • 3
  • Malvyne Rolli-Derkinderen
    • 1
    • 2
    • 3
  • Pascal Derkinderen
    • 1
    • 2
    • 4
  1. 1.Inserm, U1235NantesFrance
  2. 2.University NantesNantesFrance
  3. 3.CHU Nantes, Institut des Maladies de l’Appareil DigestifNantesFrance
  4. 4.Department of NeurologyCHU NantesNantesFrance

Personalised recommendations